We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Cabot (CBT) to Exhibit Activated Carbon Products at ACHEMA
Read MoreHide Full Article
Cabot Corporation (CBT - Free Report) will showcase products from activated carbon families namely Cabot Norit SX, Norit GSX and Norit RX, Norit CN at ACHEMA 2018, in Frankfurt, Germany from Jun 11-15. These products have been optimized for metal catalyst support.
In addition to this, the company will also feature its convenient activated carbon sample kits for precious metal catalyst support and purification of lead pharmaceutical compounds .
Cabot’s Norit activated carbon products will act as carriers for precious metals in catalyst applications. It also offers strict product specifications and an increase in the efficiency of the catalyst impregnation process, which reduces valuable testing and process time. The high crushing strength and hardness produce low abrasion that helps to avoid fines being introduced into the catalyst and reduces the loss of precious metals.
Cabot’s shares have moved up 12.3% over a year, underperforming the industry’s 15.2% gain.
Cabot incurred net loss of $173 million or $2.80 per share in the second quarter of fiscal 2018 (ended Mar 31, 2018) against net profit of $74 million or $1.19 a year ago. Barring one-time items, adjusted earnings for the reported quarter were $1.04 per share (up from 88 cents a year ago), which surpassed the Zacks Consensus Estimate of $1.00.
Cabot, during second-quarter fiscal 2018 earnings call, stated that it expects the Reinforcement Materials segment to continue strong performance for the remainder of the year on the back of strong execution in a favorable market. For the Performance Chemicals segment, it expects to maintain margins while driving volume growth.
The company sees ongoing competitive pressures to impact results in the Purification Solutions unit amid lower variable costs and higher seasonal volumes in the second half of the year. For the Specialty Fluids segment, it expects drilling activity on previously awarded projects to start and drive results for rest of the year.
FMC Corp has an expected long-term earnings growth rate of 13.6%. Its shares have gained around 22.2% over a year.
Huntsman has an expected long-term earnings growth rate of 8.3%. Its shares have moved up around 27% over a year.
Chemours has an expected long-term earnings growth rate of 15.5%. Its shares have gained around 20% over a year.
The Hottest Tech Mega-Trend of All
Last year, it generated $8 billion in global revenues. By 2020, it's predicted to blast through the roof to $47 billion. Famed investor Mark Cuban says it will produce "the world's first trillionaires," but that should still leave plenty of money for regular investors who make the right trades early.
Image: Bigstock
Cabot (CBT) to Exhibit Activated Carbon Products at ACHEMA
Cabot Corporation (CBT - Free Report) will showcase products from activated carbon families namely Cabot Norit SX, Norit GSX and Norit RX, Norit CN at ACHEMA 2018, in Frankfurt, Germany from Jun 11-15. These products have been optimized for metal catalyst support.
In addition to this, the company will also feature its convenient activated carbon sample kits for precious metal catalyst support and purification of lead pharmaceutical compounds .
Cabot’s Norit activated carbon products will act as carriers for precious metals in catalyst applications. It also offers strict product specifications and an increase in the efficiency of the catalyst impregnation process, which reduces valuable testing and process time. The high crushing strength and hardness produce low abrasion that helps to avoid fines being introduced into the catalyst and reduces the loss of precious metals.
Cabot’s shares have moved up 12.3% over a year, underperforming the industry’s 15.2% gain.
Cabot incurred net loss of $173 million or $2.80 per share in the second quarter of fiscal 2018 (ended Mar 31, 2018) against net profit of $74 million or $1.19 a year ago. Barring one-time items, adjusted earnings for the reported quarter were $1.04 per share (up from 88 cents a year ago), which surpassed the Zacks Consensus Estimate of $1.00.
Cabot, during second-quarter fiscal 2018 earnings call, stated that it expects the Reinforcement Materials segment to continue strong performance for the remainder of the year on the back of strong execution in a favorable market. For the Performance Chemicals segment, it expects to maintain margins while driving volume growth.
The company sees ongoing competitive pressures to impact results in the Purification Solutions unit amid lower variable costs and higher seasonal volumes in the second half of the year. For the Specialty Fluids segment, it expects drilling activity on previously awarded projects to start and drive results for rest of the year.
Cabot Corporation Price and Consensus
Cabot Corporation Price and Consensus | Cabot Corporation Quote
Zacks Rank & Stocks to Consider
Cabot currently carries a Zacks Rank #3 (Hold).
Better-ranked companies in the basic materials space worth considering are FMC Corporation (FMC - Free Report) , Huntsman Corporation (HUN - Free Report) and The Chemours Company (CC - Free Report) . All three stocks sport a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.
FMC Corp has an expected long-term earnings growth rate of 13.6%. Its shares have gained around 22.2% over a year.
Huntsman has an expected long-term earnings growth rate of 8.3%. Its shares have moved up around 27% over a year.
Chemours has an expected long-term earnings growth rate of 15.5%. Its shares have gained around 20% over a year.
The Hottest Tech Mega-Trend of All
Last year, it generated $8 billion in global revenues. By 2020, it's predicted to blast through the roof to $47 billion. Famed investor Mark Cuban says it will produce "the world's first trillionaires," but that should still leave plenty of money for regular investors who make the right trades early.
See Zacks' 3 Best Stocks to Play This Trend >>